|
|
Echo Contrast Agents "Safe"; FDA Should Reconsider Warnings
|
| Link ID |
4798 |
| Title |
Echo Contrast Agents "Safe"; FDA Should Reconsider Warnings |
| Url |
http://www.medscape.com/viewarticle/572902?src=rss |
| Description |
A new analysis has shown that the benefits of using ultrasound contrast agents outweigh the risks. Most important, withholding the use of such agents in patients who need them can be detrimental, says the lead investigator. Reporting her findings last week, she called on the FDA to reconsider the warnings it has placed on these products. Heartwire |
| Category |
Articles > Cardiology |
| Keywords |
|
| Date |
Apr 12, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Cardiology |
| 4. |
Valve Replacement Often Best in Low-Flow Aortic Stenosis
|
|
|
Overall, aortic valve replacement appears to be the treatment of choice in the majority of patients with low-flow/low-gradient aortic stenosis, European researchers report in the April 15th issue of the Journal of the American College of Cardiology. Reuters Health Information
|
| 5. |
BART Closes the Book on Aprotinin
|
|
|
Results from the trial -- halted last year due to safety concerns -- clearly point to increased deaths in high-risk coronary artery bypass graft patients randomized to aprotinin. Medscape Medical News
|
|
|
